The REMEDY Center will ensure research that provides better treatment in rheumatology and musculoskeletal diseases, with great significance for individuals and society.
The purpose of REMEDY is to develop excellent treatments and treatment strategies in rheumatology and musculoskeletal diseases through a broad approach to the research field.
Our ambition is to conduct clinical studies with the potential to change clinical practice.
The center has been established with Diakonhjemmet Hospital as the host institution, together with Oslo University Hospital, the University of Oslo, the Norwegian Rheumatology Association and MAGIC as associated partners.
WORK PACKAGE 3
The aim of WORK PACKAGE 3 is to identify and define phenotypes/endotypes for pain and the association between disease activity and pain.
The Norwegian study for therapeutic drug monitoring
Methotrexate in the treatment of erosive hand osteoarthritis
The Norwegian register for antirheumatic drugs.
Longitudinal observational study of people with hand osteoarthritis
To what extent are factors such as central sensitization, psychological burden, gender and systemic biomarkers associated with more severe symptoms?
Specialized rehabilitation at private rehabilitation institutions
Longitudinal ultrasound study of patients with rheumatoid arthritis starting treatment with biological DMARD drugs